| Bioactivity | WRN inhibitor 17 (Compound 250) is an orally active Werner Syndrome ATP dependent helicase enzyme (WRN) inhibitor, in particular inhibit WRN helicase domain activity. WRN inhibitor 17 is promising for research of cancers[1]. |
| CAS | 3064599-40-9 |
| Formula | C33H34F4N4O6S |
| Molar Mass | 690.70 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. DEMARTINO, Michael P., et al. CHEMICAL COMPOUNDS AND USES THEREOF. WO2024246863. 2024 December 05. |
WRN inhibitor 17
CAS: 3064599-40-9 F: C33H34F4N4O6S W: 690.70
WRN inhibitor 17 (Compound 250) is an orally active Werner Syndrome ATP dependent helicase enzyme (WRN) inhibitor, in pa
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.